NCT03209479View on ClinicalTrials.gov

"Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) Prevention of Relapse of Multiple Sclerosis"

CompletedOBSERVATIONAL
Enrollment

1,332

Participants

Timeline

Start Date

November 24, 2015

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Multiple Sclerosis
Interventions
DRUG

Glatiramer acetate

Copaxone subcutaneous injection syringe

Trial Locations (1)

Unknown

Takeda selected site, Tokyo

All Listed Sponsors
lead

Teva Takeda Pharma Ltd.

INDUSTRY

NCT03209479 - "Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) Prevention of Relapse of Multiple Sclerosis" | Biotech Hunter | Biotech Hunter